Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.56 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.56 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.54 |
| ▸ | KDM4C | Q9H3R0 | 11/20 | 0.49 |
| ▸ | KDM5A | P29375 | 8/20 | 0.49 |
| ▸ | KDM5C | P41229 | 1/20 | 0.47 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.47 |
| ▸ | KDM4A | O75164 | 3/20 | 0.46 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26495437 | 0.96 | GPR84 (0.62) | GPR84FFAR1FFAR4CAMK2AKDM4C | |
| SCHEMBL26495628 | 0.94 | GPR84 (0.67) | GPR84FFAR1FFAR4CAMK2AKDM4C | |
| SCHEMBL26495567 | 0.94 | GPR84 (0.67) | GPR84FFAR1FFAR4CAMK2AKDM4C | |
| SCHEMBL26495498 | 0.94 | GPR84 (0.67) | GPR84FFAR1FFAR4CAMK2AKDM4C | |
| SCHEMBL26495394 | 0.93 | CAMK2A (0.56) | GPR84FFAR1FFAR4CAMK2AKDM4C | |
| SCHEMBL26495428 | 0.91 | GPR84 (0.56) | GPR84FFAR1FFAR4CAMK2AKDM4C | |
| SCHEMBL26495563 | 0.89 | GPR84 (0.60) | GPR84FFAR1FFAR4CAMK2AKDM4C | |
| SCHEMBL26495495 | 0.89 | GPR84 (0.60) | GPR84FFAR1FFAR4CAMK2AKDM4C | |
| SCHEMBL14569694 | 0.89 | GPR84 (0.60) | GPR84FFAR1FFAR4CAMK2AKDM4C | |
| SCHEMBL26495389 | 0.89 | KDM4C (0.50) | GPR84FFAR1FFAR4CAMK2AKDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230320995-A1 | IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES | CAPSTAN THERAPEUTICS, INC. (US) | 2023-10-12 | — | — | US | disclosed |
| WO-2023196444-A1 | IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES | CAPSTAN THERAPEUTICS, INC. (US) | 2023-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230320995-A1 | IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES | PLTP, LNPEP, PLIN3 | GPR84 2808/4885FFAR1 1062/4885FFAR4 822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.